The effects of telmisartan on mechanical responses of left ventricular papillary muscle in rats with streptozotocin-induced diabetes mellitus

Acta Diabetologica

Volumn 47, Issue SUPPL. 1, 2010, Pages

  Emre, Mustafa ^a   Kavak, Servet ^a   Unlugenc, Hakki ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Contractility parameters; Diabetes mellitus; Heart papillary muscle; Telmisartan

Indexed keywords

STREPTOZOCIN; TELMISARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DRUG EFFECT; DRUG MECHANISM; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART MUSCLE TENSION; HEART PAPILLARY MUSCLE; HEART PROTECTION; INOTROPISM; MALE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WISTAR RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL CONTRACTION; PAPILLARY MUSCLES; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 78751582222     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0156-x     Document Type: Article

References (42)

1. Tschoepe D, Menart-Houtermans B (2002) Diabetes mellitus. In: Michelson AD (ed) Platelets. Academic Press, San Diego, pp 435-445
2. SM Haffner S Lehto T Ronnemaa K Pyorala M Laakso 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 234 1:STN:280:DyaK1czivVKgsg%3D%3D 10.1056/NEJM199807233390404 9673301 (Pubitemid 28350165)
3. S Kavak M Emre T TetIker T Kavak Z Kolcu İ Günay 2008 Effects of rosiglitazone on altered electrical left ventricular papillary muscle activities of diabetic rat Naunyn-Schmiedeberg's Arch Pharmacol 376 6 415 421 1:CAS:528:DC%2BD1cXosFajtA%3D%3D 10.1007/s00210-007-0234-y
4. M Aomine T Yamato 2000 Electrophysiological properties of ventricular muscle obtained from spontaneously diabetic mice Exp Anim 49 1 23 33 1:STN:280:DC%2BD3c3mt1Oiug%3D%3D 10.1538/expanim.49.23 10803358
5. 2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats Am J Physiol 253 2 Pt 1 E202 E207 1:CAS:528:DyaL2sXlslelsLY%3D 2956889
6. 2+ channel Cardiovasc Res 24 5 381 389 1:CAS:528:DyaK3cXmtV2htLs%3D 10.1093/cvr/24.5.381 2164883
7. 2+ currents in ventricular myocytes from rat with chronic diabetes Am J Physiol 269 HI288 HI296
8. Z Yu GF Tibbits JH McNeill 1994 Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding Am J Physiol 266 5 Pt 2 H2082 H2089 1:CAS:528:DyaK2cXktlagurc%3D 8203606
9. ZY Fang JB Prins TH Marwick 2004 Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Endocr Rev 25 543 567 1:CAS:528:DC%2BD2cXns1Ghtrc%3D 10.1210/er.2003-0012 15294881 (Pubitemid 39096070)
10. M Galderisi KM Anderson PW Wilson D Levy 1991 Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study) Am J Cardiol 68 1 85 89 1:STN:280:DyaK3M3otFKqsw%3D%3D 10.1016/0002-9149(91)90716-X 2058564
11. JR Privratsky LE Wold JR Sowers MT Quinn J Ren 2003 AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT 1 receptor and NADPH oxidase Hypertension 42 206 212 1:CAS:528: DC%2BD3sXls1ajtLo%3D 10.1161/01.HYP.0000082814.62655.85 12847113 (Pubitemid 36944598)
12. W Wienen N Hauel JC van Meel B Narr U Ries M Entzeroth 1993 Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277 Br J Pharmacol 110 245 252 1:CAS:528:DyaK2cXitlahug%3D%3D 8220885
13. HA Pershadsingh TW Kurtz 2004 Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease Diabetes Care 27 1015 10.2337/diacare.27.4.1015 15047668
14. SC Benson HA Pershadsingh CI Ho A Chittiboyina P Desai M Pravenec N Qi J Wang MA Avery TW Kurtz 2004 Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR-c-modulating activity Hypertension 43 993 1002 1:CAS:528:DC%2BD2cXjt1GmtrY%3D 10.1161/01.HYP. 0000123072.34629.57 15007034 (Pubitemid 38579904)
15. M Böhm M Lee R Kreutz, et al. 1995 Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin system gene expression and cardiovascular functions Hypertension 13 891 899 10.1097/00004872-199508000- 00010
16. M Böhm A Lippoldt W Wienen D Ganten M Bader 1996 Reduction of cardiac hypertrophy in TGR(mREN2) 27 by angiotensin II receptor blockade Mol Cell Biochem 163/164 217 221 10.1007/BF00408661
17. J Wagner M Drab J Bohlender K Amann W Wienen D Ganten 1998 Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain Clin Exp Hypertens 20 205 221 1:CAS:528:DyaK1cXit1aqt7k%3D 10.3109/10641969809053215 9533614
18. V Bonnevie-Nielsen MW Steffes A Lernmark 1981 A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin Diabetes 30 424 429 1:CAS:528:DyaL38XkvV2qtbs%3D 10.2337/diabetes.30.5.424 6453032
19. B Ramesh KV Pugalendi 2007 Influence of umbelliferone on membrane-bound ATPases in streptozotocin-induced diabetic rats Pharmacol Rep 59 349 358
20. N Bracken FC Howarth J SIngh 2006 Effects of streptozotocin-induced diabetes on contraction and calcium transport in rat ventricular cardiomyocytes Ann NY Acad Sci 1084 208 222 1:CAS:528:DC%2BD2sXpsFehtw%3D%3D 10.1196/annals.1372.018 17151303 (Pubitemid 47091952)
21. RA Brown MM Lee AM Sundareson DJ Woodbury AO Savage 1996 Influence of calcium channel blocker treatment on the mechanical properties of diabetic rat myocardium Acta Diabetol 33 7 14 1:CAS:528:DyaK28XivVegu78%3D 10.1007/BF00571933 8777289 (Pubitemid 26096149)
22. J Ren MF Walsh JR Sowers RA Brown 1999 Augmentation of the inotropic response to insulin in diabetic rat hearts Life Sci 65 369 380 1:STN:280:DyaK1MzkslOqsw%3D%3D 10.1016/S0024-3205(99)00258-1 10421423 (Pubitemid 29325280)
23. S Morimoto Y Yano K Maki K Sawada 2006 Renal and vascular protective effects of telmisartan in patients with essential hypertension Hypertens Res 29 567 572 1:CAS:528:DC%2BD28XhtFOrtrbP 10.1291/hypres.29.567 17137211 (Pubitemid 44437358)
24. A Remuzzi G Remuzzi 2006 Potential protective effects of telmisartan on renal function deterioration JRAAS 7 185 191 1:CAS:528:DC%2BD2sXjs1Wlt7k%3D 17318786
25. A Schafer U Flierl C Vogt S Menninger P Tas G Ertl J Bauersachs 2007 Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus Pharmacol Res 56 217 223 10.1016/j.phrs.2007.05.009 17669665 (Pubitemid 47321205)
26. W Wienen S Richard P Champeroux C Audeval-Gerard 2001 Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats JRAAS 2 31 36 1:CAS:528:DC%2BD3MXjtVKrtL0%3D 11881063
27. C Cheetham G O'Driscoll K Stanton, et al. 2001 Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in type II diabetes Clin Sci (Lond) 100 13 17 1:CAS:528:DC%2BD3MXnvFWnsA%3D%3D 10.1042/CS20000122 (Pubitemid 32057802)
28. Ohmura T, Tsunenari I, Seidler R, Chachin M, Hayashi T, Konomi A, Matsumaru T, Sumida T, Hayashi N, Horie Y (2007) Renoprotective effects of telmisartan on renal injury in obese Zucker rats. Acta Diabetol. Nov 16
29. Y Horie 2007 Renoprotective effects of telmisartan in the 5/6 nephrectomised rats J Renin Angiotensin Aldosterone Syst 8 2 93 100 10.3317/jraas.2007.017 17703436 (Pubitemid 47272472)
30. BM Brenner ME Cooper D de Zeeuw, et al. 2001 Effects of losartan on renal and cardio-vascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861 869 1:CAS:528:DC%2BD3MXntlelsLk%3D 10.1056/NEJMoa011161 11565518
31. LA Sechi CA Griffin M Schambelan 1994 The cardiac renin-angiotensin system in STZ-induced diabetes Diabetes 43 e1180 e1184 10.2337/diabetes.43.10. 1180
32. J Ren AJ Davidoff 1997 Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes Am J Physiol Heart Circ Physiol 272 H148 H158 1:CAS:528:DyaK2sXht1Wms7w%3D
33. K Dutta DA Podolin MB Davidson AJ Davidoff 2001 Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance Diabetes 50 1186 1192 1:CAS:528:DC%2BD3MXkvFSnsro%3D 10.2337/diabetes.50.5.1186 11334425
34. LE Wold DP Relling PB Colligan GI Scott KK Hintz BH Ren PN Epstein J Ren 2001 Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes J Mol Cell Cardiol 33 1719 1726 1:CAS:528:DC%2BD3MXms1alsL0%3D 10.1006/jmcc.2001.1431 11549350 (Pubitemid 32844229)
35. 2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats Cardiovasc Res 39 1 242 256 1:CAS:528:DyaK1cXkvF2qu78%3D 10.1016/S0008-6363(98)00081-9 9764204 (Pubitemid 28322394)
36. 2+ transients and contractile function of rat myocardium Arch Biochem Biophys 435 166 174 1:CAS:528:DC%2BD2MXos1GrsA%3D%3D 10.1016/j.abb.2004.11.027 15680918 (Pubitemid 40170027)
37. Ishikawa T, Kajiwara H, Kurihara S (1999) Am J Physiol 277: H2185-H2194
38. Satoh N, Sato T, Shimada M, Yamada K, Kitada Y (2001) J Pharm Exp Ther 298: 1161-1166
39. Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH (2002) Diabetes 51: 1166-1171
40. 2+ handling in ventricular myocytes isolated from diabetic rats Am J Physiol 270 H1529 H1537 1:CAS:528:DyaK28Xjt1Ohtb0%3D 8928857
41. Makino N, Dhalla KS, Elimban V, Dhalla NS (1987) Sarcolemmal transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol 253 (Endocrinol Metab 16): E202-E207
42. S Penpargkul F Fein EH Sonnenblick J Scheuer 1981 Depressed cardiac sarcoplasmic reticular function from diabetic rats J Mol Cell Cardiol 13 303 309 1:CAS:528:DyaL3MXhvV2rs7Y%3D 10.1016/0022-2828(81)90318-7 6115064 (Pubitemid 11155567)